ASTELLAS PHARMACEUTICALS

Astellas Pharmaceuticals Pakistan (Pvt.) Ltd. operates primarily as a trading and distribution entity.

Company Introduction:

Astellas Pharmaceuticals Pakistan (Pvt.) Ltd. is the Pakistani subsidiary of Astellas Pharma Inc., a global pharmaceutical company based in Japan. Astellas is dedicated to improving the health of people worldwide through the provision of innovative and reliable pharmaceutical products. In Pakistan, the company focuses on the sales, marketing, and distribution of a range of prescription medicines. Their product portfolio typically covers key therapeutic areas such as oncology, urology, immunology, and infectious diseases. The company plays a vital role in making Astellas' global pharmaceutical innovations accessible to patients and healthcare providers across Pakistan. Their operations in the country are primarily centered on commercial activities, including market access, sales, and distribution, rather than direct manufacturing.

Astellas Pharma in Pakistan primarily sells and distributes a range of pharmaceutical products. These products are generally manufactured in other global facilities and then imported into Pakistan.

Key products sold or distributed by Astellas Pharma in Pakistan include:

Oncology:

Xtandi (enzalutamide)

Xospata (gilteritinib)

Padcev (enfortumab vedotin)

Urology:

Betmiga (mirabegron)

Immunology and Transplant:

Prograf (tacrolimus)

Anti-infectives:

Cresemba (isavuconazonium sulfate)